Latest Regulatory Approvals News

Novomatic AG has launched an unconditional A$1.00 per share off-market takeover offer for Ainsworth Game Technology Limited, representing a 35% premium and backed by AGI's Independent Board Committee. The offer aims to consolidate Novomatic's control and potentially delist AGI from the ASX.

Novomatic AG has launched an unconditional $1.00 per share cash offer to acquire all remaining shares of Ainsworth Game Technology Limited, representing a 35% premium to pre-announcement trading prices. The offer runs alongside a terminated scheme of arrangement and comes with unanimous board backing.

Variscan Mines has secured official approval of its Restoration Plan for the Novales-Udias Zinc Project in northern Spain, unlocking the path to mine production restart and extensive exploration drilling.

Brazilian Rare Earths Limited has obtained the final regulatory approval to operate its rare earth pilot plant in Brazil’s largest petrochemical complex, setting the stage for pilot operations in mid-2026.

4DMedical has won a crucial US Medicare reimbursement for its CT, VQ™ lung imaging software, paving the way for rapid adoption across American hospitals. This milestone follows FDA clearance and promises to transform lung diagnostics with safer, faster scans.

Eclipse Metals is set to launch a diamond drilling program at its Grønnedal Rare Earth Project in Greenland, aiming to expand a substantial rare earth resource. Concurrently, assays reveal promising concentrations of critical minerals rubidium and gallium at Ivigtut, positioning the company strategically within evolving global supply chains.

Ardea Resources’ subsidiary Kalgoorlie Nickel Pty Ltd has formalised a Heritage Agreement with the Marlinyu Ghoorlie Native Title Claimant Group, paving the way for responsible development of the Goongarrie Hub Project in Western Australia.

Cambium Bio has struck a licensing deal with Keke Medtech to commercialise its fibrin biologic in dental applications, unlocking new markets and non-dilutive funding.

Race Oncology has activated its first clinical trial site in Hong Kong for the Phase 1 study of RC220 combined with doxorubicin in advanced solid tumours, marking a significant step in accelerating patient enrolment and broadening clinical data.

Black Rock Mining has locked in A$10 million through a two-tranche placement to institutional and sophisticated investors, with a Share Purchase Plan to follow, aiming to accelerate early construction at its Mahenge Graphite Project.

Latrobe Magnesium has commenced start-up operations at its Hazelwood North Demonstration Plant following EPA licence renewal, overcoming recent weather-related supply setbacks. The company aims to begin magnesium oxide production within the week as it advances toward full commissioning.

Southern Palladium has initiated a comprehensive drilling campaign at its Bengwenyama PGM project, marking a critical step toward completing its Definitive Feasibility Study in early 2026. The program aims to refine metallurgical data and mine design while regulatory approvals edge closer.